Gilead signs deals with Indian companies for low-cost HIV drug
(Reuters) - Gilead Sciences Inc signed deals with three Indian companies to drive sales and reduce manufacturing costs of low-cost generic versions of its HIV drug emtricitabine in developing countries.
Under deals with Ranbaxy Laboratories, Strides Arcolab and Mylan Inc's India unit, Gilead will provide technology and funding to help reduce manufacturing costs of the drug, the companies said.
Gilead, which sells the drug under the Emtriva brand, is the world's largest maker of branded drugs to treat the human immunodeficiency virus -- the cause of AIDS.
(Reporting by Shailesh Kuber; Editing by Viraj Nair)
- Tweet this
- Share this
- Digg this
- Alabama man claims penis was amputated by mistake
- UPDATE 7-French warplanes search Mali desert for crashed Air Algerie plane
- UPDATE 2-U.S. says Russia firing artillery over border at Ukraine military
- UPDATE 8-At least 15 killed by shelling of Gaza school; toll exceeds 760
- Gunmen said to chase investigators from MH17 crash site
Nigeria could cut the number of polio cases to zero next year and be declared free of the disease in 2018 even though a national eradication campaign has had to contend with an insurgency in the north, Bill Gates told Reuters. Full Article